F.D.A. Approves Narcan for Over-the-Counter Salesnews2023-03-29T12:45:40+00:00March 29th, 2023|The New York Times|
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles.news2023-03-28T17:05:40+00:00March 28th, 2023|The New York Times|
The Adderall Shortage Reflects Bad Drug Policynews2023-03-25T13:00:09+00:00March 25th, 2023|The New York Times|
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cutsnews2023-03-24T15:25:37+00:00March 24th, 2023|The New York Times|
Rising Rate of Drug Shortages Is Framed as a National Security Threatnews2023-03-22T20:54:10+00:00March 22nd, 2023|The New York Times|
Sanofi Plans to Cut the Price of Insulinnews2023-03-16T22:26:17+00:00March 16th, 2023|The New York Times|
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatmentnews2023-03-16T21:15:49+00:00March 16th, 2023|The New York Times|
What to Know About the Recent Eye Drop Recallsnews2023-03-16T16:50:11+00:00March 16th, 2023|The New York Times|
Texas Judge Hears Case to End Federal Approval of Abortion Pillnews2023-03-16T11:21:49+00:00March 16th, 2023|The New York Times|
